Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Cystic Fibrosis
Cystic Fibrosis News
AlertFDA Clears Tezacaftor/Ivacaftor Combo for Cystic FibrosisSymdeko is for people aged 12 years and older who have two copies of the F508del mutation in the CFTR gene or who have at least one mutation that is responsive to tezacaftor/ivacaftor.
FDA Approvals, February 13, 2018
Corbus Cystic Fibrosis Drug to Get FDA Review on Flare-up DataCorbus Pharmaceuticals Holdings Inc said on Monday the U.S. Food and Drug Administration will evaluate its experimental cystic fibrosis drug without requiring proof the product improves lung function, dramatically cutting the time and cost it will take Corbus to develop the drug.
